Phase II clinical study of cladribine in the treatment of hairy cell leukemia.
Machii T, Chou T, Suzuki M, Ohe Y, Katagiri S, Kitano EK, Kitano K, Fujiyama Y, Izumi T, Shimazaki C, Nanba K, Ohashi Y, Kitani T; Cladribine Study Group.
Machii T, et al. Among authors: katagiri s.
Int J Hematol. 2005 Oct;82(3):230-5. doi: 10.1532/IJH97.04128.
Int J Hematol. 2005.
PMID: 16207596
Clinical Trial.